Literature DB >> 9246765

Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug).

P Rossmann1, B Ríhová, J Strohalm, K Ulbrich.   

Abstract

This study compares the toxic effects of native cyclosporia A (CyA) with those of targeted CyA that is conjugated with the anti-rat-thymocyte antibody of rabbit origin via the N-(2-hydroxypropyl)methacrylamide (HPMA) carrier bearing digestible, reactive oligopeptide side chains. Ten toxic doses of native CyA (50 mg/kg i.p.) given to young adult rats in the course of 14 d produced a severe renal lesion-diffuse microvacuolization of the proximal tubules in the deep cortex, and hypergranulation of juxtaglomerular regions. Severe atrophy of the thymic medulla was documented by morphometry. In the cortex the epithelial reticular (but not deep interdigitating) cells showed ultrastructural signs of severe degeneration and lysis. The immature CD4+8+ double-positive cortical lymphocytes were preserved whereas the single-positive medullary thymocytes were greatly depleted; there was also a restriction of MHC class II antigen expression in the medulla. The number of medullary B cells was increased. The cytokeratin net was focally shrunken in the cortex and almost negative in the medulla, with loss of Hassall's corpuscles. After ten corresponding doses of antibody-targeted conjugated CyA no damage to the renal tubules and arterioles appeared and the antiGBM or immune-complex deposition was absent. The thymus had a normal medulla with numerous mature thymocytes and the cortical epithelial reticulum remained well preserved. Thus, the main toxic effects of CyA could be eliminated by targeting. The T-cell-targeted drug was tested for preserved immunosuppressive properties and non-toxic character of HPMA copolymer carrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246765     DOI: 10.1007/bf02819003

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  33 in total

1.  Molecular mechanism of immunosuppressive agents.

Authors:  G Baumann
Journal:  Transplant Proc       Date:  1992-08       Impact factor: 1.066

Review 2.  Histopathology of cyclosporine nephrotoxicity.

Authors:  M J Mihatsch; G Thiel; B Ryffel
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  Cyclosporine A-induced arteriolopathy.

Authors:  T T Antonovych; S G Sabnis; H A Austin; A G Palestine; J E Balow; R B Nussenblatt; G B Helfrich; M L Foegh; M R Alijani
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  The human thymic microenvironment: cortical thymic epithelium is an antigenically distinct region of the thymic microenvironment.

Authors:  E J McFarland; R M Scearce; B F Haynes
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Chronic injury of human renal microvessels with low-dose cyclosporine therapy.

Authors:  B D Myers; L Newton; C Boshkos; J A Macoviak; W H Frist; G C Derby; M G Perlroth; R K Sibley
Journal:  Transplantation       Date:  1988-11       Impact factor: 4.939

6.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

Review 7.  Cyclosporine, tolerance, and autoimmunity.

Authors:  G J Prud'homme; L E Vanier
Journal:  Clin Immunol Immunopathol       Date:  1993-03

8.  Reexposure to OKT3 in renal allograft recipients.

Authors:  J T Mayes; J R Thistlethwaite; J K Stuart; M R Buckingham; F P Stuart
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

9.  Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro.

Authors:  B Rihova; M Bilej; V Vetvicka; K Ulbrich; J Strohalm; J Kopecek; R Duncan
Journal:  Biomaterials       Date:  1989-07       Impact factor: 12.479

10.  Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody.

Authors:  B Ríhová; P Kopecková; J Strohalm; P Rossmann; V Vĕtvicka; J Kopecek
Journal:  Clin Immunol Immunopathol       Date:  1988-01
View more
  3 in total

Review 1.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 2.  Morphology and immunohistochemistry of rat aortic grafts.

Authors:  P Rossmann; J Lácha; A Lodererová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

3.  Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.

Authors:  Lubomir Kovar; Tomas Etrych; Martina Kabesova; Vladimir Subr; David Vetvicka; Ondrej Hovorka; Jiri Strohalm; Jan Sklenar; Petr Chytil; Karel Ulbrich; Blanka Rihova
Journal:  Tumour Biol       Date:  2010-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.